arrow
A

Anne J. Novak

mayo clinic rochester
H指数:57
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL

晚期复发的基准分子特征:识别弥漫性大B细胞淋巴瘤延迟复发的驱动因素

2026-10-130
OAAI
Perinatal and Early-Life Exposures and Risk of Non-Hodgkin Lymphoma

围产期和早期生命暴露与非霍奇金淋巴瘤风险

Cancers
IF4.4
2026-08-280
OA
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenström macroglobulinemia

多组学分析揭示MYD88野生型华氏巨球蛋白血症中存在独特的表观遗传特征

2026-05-010
OA
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes

血清中高水平的可溶性肿瘤坏死因子受体2与主要淋巴瘤亚型的不良总生存期相关

2026-03-270
PRE
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes

血液恶性肿瘤家族史与非霍奇金淋巴瘤亚型的预后关系

2026-03-100
OA
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study

胰岛素样生长因子I(IGF-I)循环水平与多发性骨髓瘤风险:一项观察性和孟德尔随机化研究

2026-03-010
OAAI
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy

滤泡性淋巴瘤患者一线免疫化疗后的无事件生存期全基因组关联研究

2026-01-090
OAAI
Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma

开发和验证一种用于预测滤泡性淋巴瘤患者早期事件的基因表达谱

2025-09-220
OAAI
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts

滤泡性淋巴瘤3B亚型具有不同的预后结局:来自前瞻性多中心MER和LEO队列的研究结果

2025-08-080
OAAI
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

整合基因组学与精细的细胞起源亚型划分,区分了弥漫性大B细胞淋巴瘤中特定亚型的治疗抵抗和复发机制。

2025-07-120
OAAI
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
2024-11-290
OAAI
Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot

检测淋巴瘤的血浆甲基化DNA标记: 发现,验证和临床试点

2024-11-200
OAAI
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
2024-10-090
OAAI
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
2024-08-080
OAAI
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
2024-06-202
OAAI